GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » 10-Year RORE %

Opsens (TSX:OPS) 10-Year RORE % : 7.78% (As of Aug. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Opsens 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Opsens's 10-Year RORE % for the quarter that ended in Aug. 2023 was 7.78%.

The industry rank for Opsens's 10-Year RORE % or its related term are showing as below:

TSX:OPS's 10-Year RORE % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.18 vs TSX:OPS: 7.78

Opsens 10-Year RORE % Historical Data

The historical data trend for Opsens's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens 10-Year RORE % Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.49 -2.07 -5.77 12.22 7.78

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.22 11.61 11.24 10.72 7.78

Competitive Comparison of Opsens's 10-Year RORE %

For the Medical Instruments & Supplies subindustry, Opsens's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opsens's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Opsens's 10-Year RORE % falls into.



Opsens 10-Year RORE % Calculation

Opsens's 10-Year RORE % for the quarter that ended in Aug. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( -0.11--0.06 )/( -0.643-0 )
=-0.05/-0.643
=7.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Aug. 2023 and 10-year before.


Opsens  (TSX:OPS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Opsens 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Opsens's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines